1-6 of 6
Ayako Muramatsu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

Ayako Muramatsu, Ayumi Fujimoto, Koji Izutsu, Tsutomu Kobayashi, Takahiro Fukuda, Go Yamamoto, Yasufumi Uehara, Masashi Sawa, Nobuhiro Hiramoto, Tsuyoshi Muta, Keisuke Kataoka, Yoshinobu Kanda, Jun Ishikawa, Makoto Onizuka, Koji Kawamura, Junya Kanda, Yoshiko Atsuta, Junya Kuroda, Shinichi Kako, Ritsuro Suzuki
Journal: Blood
Blood (2024) 144 (Supplement 1): 4472.
https://doi.org/10.1182/blood-2024-206515
Published: 2024
Journal Articles

The Anti-Myeloma Efficacy of TAS0612, a Triple Inhibitor of RSK, AKT, and S6K, and Itssynergistic Combination with Venetoclax in Multiple Myeloma Irrespective of Cytogeneticabnormalities

Haruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto, Yoko Katsuragawa-Taminishi, Yuka Kawaji-Kanayama, Kentaro Mizuhara, Ayako Muramatsu, Reiko Isa, Takahiro Fujino, Yuji Shimura, Koji Ichikawa, Junya Kuroda
Journal: Blood
Blood (2024) 144 (Supplement 1): 4178.
https://doi.org/10.1182/blood-2024-199695
Published: 2024
Journal Articles

The Activation Status of RSK2, but Not PDPK1 and AKT, Associates with the Prognosis of Diffuse Large B Cell Lymphoma

Akio Onishi, Aya Miyagawa-Hayashino, Kentaro Mizuhara, Ayako Muramatsu, Haruya Okamoto, Yuka Kawaji-Kanayama, Yoko Katsuragawa-Taminishi, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Eiichi Konishi, Junya Kuroda
Journal: Blood
Blood (2023) 142 (Supplement 1): 4390.
https://doi.org/10.1182/blood-2023-184365
Published: 2023
Journal Articles

TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, Is a Promising Anti-Myeloma Agent Regardless of Types of Cytogenetic/Genetic Abnormality

Haruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto, Yoko Katsuragawa-Taminishi, Reiko Isa, Kentaro Mizuhara, Ayako Muramatsu, Yuka Kawaji-Kanayama, Takahiro Fujino, Yuji Shimura, Junya Kuroda
Journal: Blood
Blood (2023) 142 (Supplement 1): 3313.
https://doi.org/10.1182/blood-2023-174157
Published: 2023
Journal Articles

The Universal Antitumor Activity of TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, in B-Cell Lymphomas Regardless of Disease Subtype

Yoko Katsuragawa-Taminishi, Shinsuke Mizutani, Yuka Kawaji-Kanayama, Akio Onishi, Haruya Okamoto, Reiko Isa, Kentaro Mizuhara, Ayako Muramatsu, Takahiro Fujino, Taku Tsukamoto, Yuji Shimura, Masafumi Taniwaki, Aya Miyagawa-Hayashino, Eiichi Konishi, Junya Kuroda
Journal: Blood
Blood (2023) 142 (Supplement 1): 7135.
https://doi.org/10.1182/blood-2023-173485
Published: 2023
Journal Articles

Mir-106a-5p and Mir-146a-5p Delivered By Tumor-Derived Exosomes Promote the Induction of Myeloid-Derived Suppressor Cells from Normal Peripheral Blood Mononuclear Cells in Multiple Myeloma

Kentaro Mizuhara, Yuji Shimura, Taku Tsukamoto, Akinori Kanai, Saeko Kuwahara-Ota, Junko Yamaguchi, Ayako Muramatsu, Haruya Okamoto, Yoko Katsuragawa-Taminishi, Yuka Kawaji-Kanayama, Reiko Isa, Shinsuke Mizutani, Toshiya Inaba, Junya Kuroda
Journal: Blood
Blood (2022) 140 (Supplement 1): 9949–9950.
https://doi.org/10.1182/blood-2022-160408
Published: 2022